HK1147035A1 - Indoline anti-cancer agents - Google Patents

Indoline anti-cancer agents

Info

Publication number
HK1147035A1
HK1147035A1 HK11101090.4A HK11101090A HK1147035A1 HK 1147035 A1 HK1147035 A1 HK 1147035A1 HK 11101090 A HK11101090 A HK 11101090A HK 1147035 A1 HK1147035 A1 HK 1147035A1
Authority
HK
Hong Kong
Prior art keywords
indoline
cancer agents
cancer
agents
indoline anti
Prior art date
Application number
HK11101090.4A
Other languages
English (en)
Chinese (zh)
Inventor
Gunnar James Hanson
Qi Wei
Charles Caldwell
Ming Zhou
Lai Wang
Susan Harran
Original Assignee
Joyant Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Joyant Pharmaceuticals Inc filed Critical Joyant Pharmaceuticals Inc
Publication of HK1147035A1 publication Critical patent/HK1147035A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
HK11101090.4A 2008-04-29 2011-02-01 Indoline anti-cancer agents HK1147035A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4886908P 2008-04-29 2008-04-29
US11206208P 2008-11-06 2008-11-06
PCT/US2009/042181 WO2009134938A1 (en) 2008-04-29 2009-04-29 Indoline anti-cancer agents

Publications (1)

Publication Number Publication Date
HK1147035A1 true HK1147035A1 (en) 2011-07-29

Family

ID=41255403

Family Applications (1)

Application Number Title Priority Date Filing Date
HK11101090.4A HK1147035A1 (en) 2008-04-29 2011-02-01 Indoline anti-cancer agents

Country Status (8)

Country Link
US (2) US7989482B2 (xx)
EP (1) EP2268146B1 (xx)
JP (1) JP5123429B2 (xx)
CN (1) CN102014632B (xx)
AU (1) AU2009243056B2 (xx)
CA (1) CA2720516C (xx)
HK (1) HK1147035A1 (xx)
WO (1) WO2009134938A1 (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7851620B2 (en) * 2007-06-07 2010-12-14 Board Of Regents, The University Of Texas System Methods for preparing diazonamides
DK2699580T3 (en) * 2011-04-22 2018-01-08 Joyant Pharmaceuticals Inc DIAZONAMI DISEASES
EP3036226B1 (en) * 2013-08-22 2020-01-08 The General Hospital Corporation Inhibitors of human 12/15-lipoxygenase

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4261989A (en) 1979-02-19 1981-04-14 Kaken Chemical Co. Ltd. Geldanamycin derivatives and antitumor drug
US5387584A (en) 1993-04-07 1995-02-07 Pfizer Inc. Bicyclic ansamycins
US5932566A (en) 1994-06-16 1999-08-03 Pfizer Inc. Ansamycin derivatives as antioncogene and anticancer agents
US5624677A (en) 1995-06-13 1997-04-29 Pentech Pharmaceuticals, Inc. Controlled release of drugs delivered by sublingual or buccal administration
EP1289989A2 (en) 2000-06-07 2003-03-12 Lilly Icos LLC Derivatives of 2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione
CA2426952C (en) 2000-11-02 2012-06-26 Sloan-Kettering Institute For Cancer Research Small molecule compositions for binding to hsp90
US7517895B2 (en) 2001-08-24 2009-04-14 Board Of Regents, The University Of Texas System Synthetic diazonamides
US7022720B2 (en) 2001-08-24 2006-04-04 Board Of Regents, The University Of Texas System Synthetic diazonamides as novel anti-mitotic agents
EA010160B1 (ru) 2003-09-18 2008-06-30 Конформа Терапьютикс Корпорейшн Новые гетероциклические соединения - ингибиторы hsp90 и способы их получения
US7538129B2 (en) 2005-10-31 2009-05-26 Board Of Regents, The University Of Texas System Diazonamide A analog
US7851620B2 (en) 2007-06-07 2010-12-14 Board Of Regents, The University Of Texas System Methods for preparing diazonamides

Also Published As

Publication number Publication date
US20120264763A1 (en) 2012-10-18
CN102014632B (zh) 2014-05-28
US8334311B2 (en) 2012-12-18
WO2009134938A1 (en) 2009-11-05
US7989482B2 (en) 2011-08-02
CA2720516C (en) 2013-10-01
CA2720516A1 (en) 2009-11-05
JP2011524855A (ja) 2011-09-08
JP5123429B2 (ja) 2013-01-23
EP2268146A4 (en) 2012-05-02
US20100035946A1 (en) 2010-02-11
AU2009243056B2 (en) 2015-05-14
AU2009243056A1 (en) 2009-11-05
EP2268146B1 (en) 2015-08-26
EP2268146A1 (en) 2011-01-05
CN102014632A (zh) 2011-04-13

Similar Documents

Publication Publication Date Title
HK1256310A1 (zh) N-磺酰基吡咯衍生物
IL210548A0 (en) Spiroaminodihydrothiazine derivatives
EP2376494A4 (en) DIHYDROPYRIMIDOPIRYMIDINE DERIVATIVES
ZA201100799B (en) Imidazopyridin-2-one derivatives
IL211180B (en) Attached polyethylene glycol and docetaxel
SG10201506608RA (en) 3-deazaneplanocin derivatives
ZA201100876B (en) Pyrrolopyridinylpyrimidin-2-ylamine derivatives
EP2291078A4 (en) OXAZOLBENZIMIDAZOLDERIVATE
ZA201102449B (en) Morpholinopurine derivatives
EP2279532A4 (en) OXAZOLBENZIMIDAZOLDERIVATE
ZA201100539B (en) Oxindole compounds
IL210869A0 (en) Imidazothiadiazoles derivatives
IL208336A0 (en) Pyrisazinone derivatives
ZA201100948B (en) Acylaminobenzamide derivatives
IL210164A0 (en) Thiazolylpiperidine derivatives
ZA201105050B (en) Quinazolinamide derivatives
ZA201008052B (en) 2-phenyl-4-cyclopropyl-pyrimidine derivatives
TWI368572B (en) Printing-table arrangement
EP2292613A4 (en) DIHYDROINDOLINONDERIVATE
IL212375A0 (en) Naphthamides as anticancer agents
HK1147035A1 (en) Indoline anti-cancer agents
IL207859A0 (en) Combination anti-cancer agents
IL213051A0 (en) Difluorophenyldiacylhydrazide derivatives
GB2463042B (en) Stabalizer arrangement
AU4585P (en) WES05 Westringia fruticosa

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20200426